Behavioral and biomedical combination strategies for HIV prevention

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 8, 2012, Pages

  Bekker, Linda Gail ^a   Beyrer, Chris ^b   Quinn, Thomas C ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CIRCUMCISION; CONDOM USE; DRUG ABUSE; EVIDENCE BASED PRACTICE; FEMALE CONDOM; HEALTH PROGRAM; HERPES SIMPLEX; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MATHEMATICAL MODEL; MEN WHO HAVE SEX WITH MEN; META ANALYSIS (TOPIC); NONHUMAN; PATIENT COUNSELING; POLICY; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMICS; VIRUS LOAD; VIRUS TRANSMISSION; BEHAVIOR THERAPY; BIOLOGICAL MODEL; CONDOM; COUNSELING; DISEASE TRANSMISSION; FEMALE; HEALTH PROMOTION; HETEROSEXUALITY; MALE; MALE HOMOSEXUALITY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; REVIEW; RISK REDUCTION; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; BEHAVIOR THERAPY; CIRCUMCISION, MALE; COMBINED MODALITY THERAPY; CONDOMS; COUNSELING; FEMALE; HEALTH PROMOTION; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, BIOLOGICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK REDUCTION BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84865634677     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007435     Document Type: Article

References (145)

1. Allen S, Meinzen-Derr J, Kautzman M, Zulu I, Trask S. 2003. Sexual behavior of HIV discordant couples after HIV counseling and testing. Aids 17: 733-740.
2. Auerbach J, Coates T. 2000. HIV prevention research: Accomplishments and challenges for the third decade of AIDS. Am J Public Health 90: 1029-1032.
3. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. 2005. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med 2: e298. doi: 10. 1371/journal. pmed. 0020298.
4. AVAC. 2007. A new way to protect against HIV? Understanding the results of male circumcision studies for HIV prevention. AIDS Vaccine Advocacy Coalition's Anticipating and Understanding Results series, September 2007, updated ed.
5. Baggaley RF, Garnett GP, Ferguson NM. 2006. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med 3: e124. doi: 10. 1371/journal. pmed. 0030124.
6. Bailey RC, Plummer FA, Moses S. 2001. Male circumcision and HIV prevention: Current knowledge and future research directions. Lancet Infect Dis 1: 223-231.
7. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. 2007. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 369: 643-656.
8. Barouche D. 2008. Challenges in the development of an HIV-1 vaccine. Nature 455: 613-617.
9. Bateganya MH, Abdulwadud OA, Kiene SM. 2007. Home-based HIV voluntary counseling and testing in developing countries. Cochrane DB Syst Rev 4: CD006493.
10. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. 2010. Time to act: A call for comprehensive responses to HIV in people who use drugs. Lancet 376: 551-563.
11. Bongaarts J, Reining P, Way P, Conant F. 1989. The relationship between male circumcision and HIV infection in African populations. AIDS 3: 373-377.
12. Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum CL, Seage GR III., Judson FN, McKirnan D, Mayer KH, Koblin BA. 2005. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 39: 82-89.
13. Caldwell JC, Caldwell P. 1996. The African AIDS epidemic. Sci Am 274: 62-63, 66-68.
14. Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. 2005. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 40: 96-101.
15. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, et al. 2008. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomised, double-blind, placebo-controlled trial. Lancet 371: 2109-2119.
16. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, BaetenJM, Mullins JI, Hughes JP, et al. 2010. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 427-439.
17. Coates T, Richter L, Caceres C. 2008. Behavioural strategies to reduce HIV transmission: How to make them work better. Lancet 372: 669-684.
18. Coffey PS, Kilbourne-Brook M, Austin G, Seamans Y, Cohen J. 2006. Short-term acceptability of the PATH woman's condom among couples at three sites. Contraception 73: 588-593.
19. Cohen J. 2005. HIV/AIDS: Prevention cocktails: Combining tools to stop HIV's spread. Science 309: 1002-1005.
20. Cohen M, Hoffman I, Royce R, Kazembe P, Dyer JR, Costello Daly C, Zimba D, Vernazza PL, Maida M, et al. 1997. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 349: 1868-1873.
21. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, KumarasamyN, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
22. Cohen MS, Gay C, Kashuba ADM, Blower S, Paxton L. 2007. Narrative Review: Antiretroviral therapy for prevention of the sexual transmission of HIV-1. Ann Intern Med 146: 591-601.
23. Collins C, Coates TJ, Curran J. 2008. Moving beyond the alphabet soup of HIV prevention. AIDS 22 (Suppl. 2): S5-S8.
24. Corbett EL, Makamure B, Cheung YB, Dauya E, Matambo R, Bandason T, MunyatiSS, Mason PR, Butterworth AE, Hayes RJ. 2007. HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS 21: 483-489.
25. Cowan FM, Pascoe SJS, Langhaug LF, Dirawo J, Mavhu W, Chidiya S, Jaffar S, Mbizuo M, Stephenson JM, Johnson AM, et al. 2009. The Regai Dzive Shiri Project: The results of a cluster randomized trial of a multi-component HIV prevention intervention for young people in rural Zimbabwe. 18th International Society for Sexually Transmitted Disease Research, London.
26. Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC. 2000. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 14: 415-421.
27. De Cock KM, Crowley SP, Lo Y.-R, Granich RM, Williams BG. 2009. Preventing HIV transmission with antiretrovirals. B World Health Organ 87: 488-488A.
28. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. 2010. Prevention for people who inject drugs: Why individual, structural, and combination approaches are required. Lancet 376: 285-301.
29. Denison JA, O'Reilly KR, Schmid GP, Kennedy CE, Sweat MD. 2008. HIV voluntary counseling and testing and behavioral risk reduction in developing countries: A meta-analysis, 1990-2005. Aids Behav 12: 363-373.
30. Donoval BA, Landay AL, Moses S, Agot K, Ndinya-Achola JO, Nyagaya EA, MacLean I, Bailey RC. 2006. HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 125: 386-391.
31. Drew WL, Blair M, Miner RC, Conant M. 1990. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 17: 110-112.
32. Drucker E, Lurie P, Wodak A, Alcabes P. 1998. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 12: S217-S230.
33. Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, Greenberg L, Allen S. 2008. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: An analysis of survey and clinical data. Lancet 371: 2183-2191.
34. Eaton L, Kalichman SC. Behavioral aspects of male circumcision for the prevention of HIV infection. Curr HIV/AIDS Rep 6: 187-193.
35. Eron JJ Jr., Gilliam B, Fiscus S, Dyer J, Cohen MS. 1996. HIV-1 shedding and chlamydial urethritis. JAMA 275: 36.
36. Fang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, ChuangCY. 2004. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis 190: 879-885.
37. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, Mulenga J, KasoloF, Vermund SH, Aldrovandi GM. 2001. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retrov 17: 901-910.
38. Fink AJ. 1986. In defense of circumcision. Pediatrics 77: 265-267.
39. Foss AM, Hossain M, Vickerman PT, Watts CH. 2007. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia. Sex Transm Infect 83: 510-516.
40. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 20: 73-83.
41. French PP, Latka M, Gollub EL, Rogers C, Hoover DR, Stein ZA. 2003. Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis 30: 433-439.
42. Galvao LW, Oliveira LC, Diaz J, Kime D-J, Marchif N, van Damg J, Castilhoc RF, Chenh M, Maurizio M. 2005. Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: A randomized trial. Contraception 71: 130-136.
43. Ghys P, Fransen K, Diallo O, Ettiègne-Traoré V, Coulibaly IM, Yeboué KM, Kalish ML, Maurice C, Whitaker JP, Greenberg AE, et al. 1997. The associations between cervicovaginal HIV shedding, sexually transmitted diseases, and immunosuppression in sex workers in Abidjan, Cote d'Ivoire. AIDS 11: F85-F93.
44. Golden M. 2006. HIV serosorting among men who have sex with men: Implications for prevention. 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO, abstract 163.
45. Granich R, Gilks C, Dye C, DeCock K, Williams B. 2009. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373: 48-57.
46. Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, Lo YR, Souteyrand Y, Williams B. 2010. Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc 13: 1.
47. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, et al. 2010. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-2599.
48. Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, et al. 2000. Male circumcision and HIV acquisition and transmission: Cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 14: 2371-2381.
49. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC, Rakai Project Team, et al. 2001. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357: 1149-1153.
50. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, et al. 2007. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 369: 657-666.
51. Gregson S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, Mason PR, Garnett GP, Chandiwana SK, Foster G, Anderson RM. 2007. Impact and process evaluation of integrated community and clinic-based HIV-1 control: A cluster-randomised trial in eastern Zimbabwe. PLoS Med 4: e102. doi: 10. 1371/journal. pmed. 0040102.
52. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. 2000. Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials. Lance 355: 1981-1987.
53. Grulich AE, Hendry O, Clark E, Kippax S, Kaldor JM. 2001. Circumcision and male-to-male sexual transmission of HIV. AIDS 15: 1188-1189.
54. Gupta GR, Parkhurst J, Ogden J, Aggleton P, Mahal A. 2008. Structural approaches to HIV prevention. Lancet 372: 765-775.
55. Hall J. 2006. Microfinance brief: Tap and reposition youth (TRY) program. Population Council, New York.
56. Hallman K. 2005. Gendered socioeconomic conditions and HIV risk behaviours among young people in South Africa. Afr J AIDS Res 4: 37-50.
57. Hallman K. 2006. HIV vulnerability of non-enrolled and urban poor girls in Kwa-Zulu Natal, South Africa. Population Council, New York.
58. Harding R, Golombok S, Sheldon J. 2000. A clinical trial of a thicker versus a standard condom for gay men. 13th International AIDS Conference, Durban. Abstract WePpC1395.
59. Hargreaves J, Atsbeha T, Gear J, Kim J, Mzamani Makhubele B, Mashaba K, Morison L, Motsei M, Peters C, Porter J, et al. 2002. Social interventions for HIV/AIDS: Intervention with microfinance for AIDS gender equity. IMAGE Study Evaluation Monograph. RADAR and Small Enterprise Foundation Publishers.
60. Hayes R, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit J. 2010. Treatment of sexually transmitted infections for HIV prevention: End of the road or new beginning? AIDS 24: S15-S26.
61. Helleringer S, Kohler HP, Frimpong JA, Mkandawire J. 2009. Increasing uptake of HIV testing and counseling among the poorest in sub-Saharan countries through home-based service provision. J Acquir Immune Defic Syndr 51: 185-193.
62. Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, Puren A, Duvvury N. 2008. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: Cluster randomised controlled trial. BMJ 337: a506. doi: 10. 1136/bmj. a506.
63. Jürgens R, Csete J, Amon J, Baral S, Beyrer C. 2010. People who use drugs, HIV and human rights. Lancet 376: 355-366.
64. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, OjwiyaA, Hughes P, Carpenter LM, Whitworth J, et al. 2003. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: A community randomised trial. Lancet 361: 645-652.
65. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, KharsanyAB, Sibeko S, Mlisana KP, Omar Z, et al. 2010. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.
66. Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, McFarlandW, et al. 2002. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 92: 388-394.
67. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, MacDonald KS, Maclean IW, Bwayo JJ, Temmerman M, et al. 2004. Monthly antiobiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: A randomized controlled study. JAMA 291: 2555-2562.
68. Kerrigan D, Moreno L, Rosario S, Gomez B, Jerez H, Barrington C, Weiss E, Sweat M. 2006. Environmental-structural interventions to reduce HIV/STI risk among female sex workers in the Dominican Republic. Am J Public Health 96: 120-125.
69. Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, van Rooyen H, Chingono A, Modiba P, Mrumbi K, Visrutaratna S, Singh B, et al. 2008. Project accept (HPTN 043): A community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr 49: 422-431.
70. Kippax S, Race K. 2003. Sustaining safe practice: Twenty years on. Soc Sci Med 57: 1-12.
71. Koblin B, Chesney M, Coates TJ, for the EXPLORE Study Team. 2004. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: The EXPLORE randomised controlled study. Lancet 364: 41-50.
72. Kong X, Kigozi G, Ssempija V, Serwadda D, Nalugoda F, Makumbi F, Lutako T, Watya S, Wawer M, Gray R. 2011. Longer-term effects of male circumcision on HIV incidence and risk behaviors during post-trial surveillance in Rakai, Uganda. 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), Boston, February 27-March 2. Abstract 36.
73. Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalaw NN, Lawn SD, Bekker L-G, Wood R. 2010. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One 5: e13801. doi: 10. 1371/journal. pone. 0013801.
74. Laga M, Alary M, Nzila N, Manoka AT, Tuliza M, Behets F, Goeman J, St LouisM, Piot P. 1994. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 344: 246-248.
75. Lampinen TM, Critchlow CW, Kuypers JM, Hurt CS, Nelson PJ, Hawes SE, Coombs RW, Holmes KK, Kiviat NB. 2000. Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men. AIDS 14: F69-F75.
76. Legakos S, Gable A. 2008. Challenges to HIV prevention-Seeking effective measures in the absence of a vaccine. N Engl J Med 358: 1543-1545.
77. Lurie MN, Williams B, Zuma K, Mkaya-Mwamburi D, Garnett G, Sturm AW, Sweat MD, Gittelsohn J, Abdool Karim SS. 2003. The impact of migration on HIV-1 transmission in South Africa. Sex Transm Dis 30: 149-156.
78. Lyle CD, Routson LB, Seaborn GB, Dixon LG, Bushar HF, Cyr WH. 1997. An in vitro evaluation of condoms as barriers to a small virus. Sex Transm Dis 24: 161-164.
79. Mathers B, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee S, Wodak A, Panda S, Tyndall M, Toufik A, et al. 2008. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 372: 1733-1745.
80. Matovu JK, Makumbi FE. 2007. Expanding access to voluntary HIV counselling and testing in sub-Saharan Africa: Alternative approaches for improving uptake, 2001-2007. Trop Med Int Health 12: 1315-1322.
81. McCoombe SG, Short RV. 2006. Potential HIV-1 target cells in the human penis. AIDS 20: 1491-1495.
82. Merson M, Padian N, Coates TJ, Gupta GR, Bertozzi SM, Piot P, Mane P, BartonM. Lancet HIV Prevention Series authors. 2008. Combination HIV prevention. Lancet 372: 1805-1806.
83. Metzger DS, Navaline H, Woody GE. 1999. Drug abuse treatment as AIDS prevention. Public Health 113: 97-106.
84. Microbicide Trials Network. 2011. Researchers reformulate tenofovir vaginal gel for rectal use. http: //www. mtnstopshiv. org/node/2934.
85. Moses S, Bradley JE, Nagelkerke NJ, Ronald AR, Ndinya-Achola JO, PlummerFA. 1990. Geographical patterns of male circumcision practices in Africa: Association with HIV seroprevalence. Int J Epidemiol 19: 693-697.
86. Musicco M, Lazzarin A, Nicolosi A, Gasparini M, Costigliola P, Arici C, SaraccoA. 1994. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med 154: 1971-1976.
87. Myron S, Cohen YQ, Chen M, McCauley T, Gamble MC, Hosseinipour N, Kumarasamy JG, Hakim J, Kumwenda J, Grinsztejn B, et al. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
88. Nabel GJ. 2001. Challenges and opportunities for development of an AIDS vaccine. Nature 410: 1002-1007.
89. Nagot N, Ouedraogo A, Foulongne V, Konaté I, Weiss HA, Vergne L, Defer M-C, Djagbaré D, Sanon A, Andonaba J-B, et al. 2007. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 356: 790-799.
90. Over M. 1998. The effect of societal variables on urban rates of HIV infection in developing countries: An exploratory analysis. In Confronting AIDS: The evidence from the developing world (ed. Ainsworth M, et al.), pp. 39-51. World Bank, Washington, DC.
91. Padian N, Buve A, Balkus J, Serwadda D, Cates W. 2008. Biomedical intervention to prevent HIV infection: Evidence, challenges, and way forward. Lancet 372: 585-599.
92. Padian N, McCoy S, Balkus J, Wasserheit J. 2010. Weighing the gold in the gold standard: Challenges in HIV prevention research. AIDS 24: 621-635.
93. Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC. 2002. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 161: 867-873.
94. Patterson TL, Mausbach B, Lozada R, Staines-Orozco H, Semple SJ, Fraga-VallejoM, Orozovich P, Abramovitz D, de la Torre A, Amaro H, et al. 2008. Efficacy of a brief behavioral intervention to promote condom use among female sex workers in Tijuana and Ciudad Juarez, Mexico. Am J Public Health 98: 2051-2057.
95. PEPFAR. 2008. Prevention for positives. http: //www. pepfar. gov/press/92934. htm (accessed April 24, 2008).
96. Pepin J, Plummer FA, Brunham RC. 1989. The interaction of HIV infection and other sexually transmitted diseases: An opportunity for intervention. AIDS 3: 3-9.
97. Pinkerton SD, Abramson PR. 1997. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 44: 1303-1312.
98. Piot P, Bartos M, Larson H, Zewdie D, Mane P. 2008. Coming to terms with complexity: A call to action for HIV prevention. Lancet 372: 845-859.
99. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. 2004. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18: 81-88.
100. Prata N, Vahidnia F, Fraser A. 2005. Gender and relationship differences in condom use among 15-24-year-olds in Angola. Int Fam Plan Perspec 31: 192-199.
101. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. 2000. A study in rural Uganda of heterosexual transmission of human immunodeficiency virus. N Engl J Med 343: 364.
102. Rehle T, Hallett T, Shisana O, Pillay-van Wyk V, Zuma K, Carrara H, Jooste S. 2010. A decline in new HIV infections in South Africa: Estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One 5: e11094.
103. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Nakorn P, Namwat C, de Souza M, Adams E, et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
104. Reynolds SJ, Shepherd ME, Risbud AR, Gangakhedkar RR, Brookmeyer RS, Divekar AD, Mehendale SM, Bollinger RC. 2004. Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 363: 1039-1040.
105. Ross DA, Changalucha J, Obasi A, Todd J, Plummer ML, Cleopas-Mazige B, Anemona A, Everett D, Weiss HA, Mabey DC, et al. 2007. Biological and behavioral impact of an adolescent sexual health intervention in Tanzania: A community-randomized trial. AIDS 21: 1943-1955.
106. Rottingen J-A, Cameron D, Garnett G. 2001. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV. How much really is known? Sex Transm Dis 28: 579-597.
107. Schneider JA, Lakshmi V, Dandona R, Kumar GA, Sudha T, Dandona L. 2010. Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India. N Engl J Med 362: 427-439.
108. Shisana O, Rehele T, Simbayi L, Zuma K, Jooste S. 2009. South African national prevalence, incidence, behaviour and communication survey, 2008. In A turning tide among teenagers?, HSRC, Cape Town, South Africa.
109. Shugars DC, Slade GD, Patton LL, Fiscus SA. 2000. Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 432-440.
110. Slutkin G, Okware S, Naamara W, Sutherland D, Flanagan D, Carael M, Blas E, Delay P, Tarantola D. 2006. How Uganda reversed its HIV epidemic. AIDS Behav 10: 351-360.
111. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. 1988. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260: 1429-1433.
112. Stoneburner RL, Low-Beer D. 2004. Population-level HIV declines and behavioral risk avoidance in Uganda. Science 304: 714-718.
113. Strathdee S, Hallett T, Bobrova N, Rhodes T, Booth R, Abdool R, Hankins CA. 2010. HIV and the risk environment among people who inject drugs: Past, present, and projections for the future. Lancet 376: 268-284.
114. Sumartojo E, Doll L, Holtgrave D, Gayle H, Merson M. 2000. Enriching the mix: Incorporating structural factors into HIV prevention. AIDS 14: S1.
115. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, GrinsteadO, Coates T. 2000. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356: 113-121.
116. The Voluntary HIV-1 Counseling Testing Efficacy Study Group. 2000. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: A randomised trial. Lancet 356: 103-112.
117. Thomsen SC, Ombidi W, Toroitich-Ruto C, Wong EL, Tucker HO, Homan R, Kingola N, Luchters S. 2006. A prospective study assessing the effects of introducing the female condom in a sex worker population in Mombasa, Kenya. Sex Transm Infect 82: 397-402.
118. Tovanabutra S, Robison V, Wongtrakul J, Sennum S, Suriyanon V, Kingkeow D, Kawichai S, Tanan P, Duerr A, Nelson KE, et al. 2002. Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immune Defic Syndr 29: 275-283.
119. UNAIDS. 2000. Evaluation of the 100% condom programme in Thailand, case study. Geneva: Joint United Nations Programme on HIV/AIDS.
120. UNAIDS. 2006. Report on the global AIDS epidemic. Geneva.
121. UNAIDS. 2007. AIDS epidemic update. Geneva: Joint United Nations Programme on HIV/AIDS.
122. UNAIDS. 2008. Report for the global AIDS epidemic. UNAIDS, Geneva.
123. UNAIDS. 2009. Condoms and HIV prevention: Position statement by UNAIDS, UNFPA and WHO. Geneva.
124. UNAIDS/WHO. 2004. UNAIDS/WHO policy statement on HIV testing. Geneva, Switzerland.
125. UNAIDS and WHO. 2007. New data on male circumcision and HIV prevention: Policy and programme implications; WHO/UNAIDS technical consultation male circumcision and HIV prevention: Research implications for policy and programming Montreux. Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization.
126. UNFPA. 2007. Donor support for contraceptives and condoms for STI/HIV prevention. Geneva.
127. Vandenbruaene M. 2007. King Kennard Holmes-Chair of the Department of Global Health of the University of Washington. Lancet Infect Dis 7: 516-520.
128. van Schaik N, Kranzer K, Wood R, Bekker LG. 2010. Earlier HIV diagnosis-are mobile services the answer? S Afr Med J 100: 671-674.
129. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, Boggian K, CohenMS, Fiscus SA, Eron JJ. 2000. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 14: 117-121.
130. Vogel UF. 2007. Towards universal access to prevention, treatment and care: Experiences and challenges from the Mbeya region in Tanzania-A case study. InUNAIDS best practices collection. Joint United Nations Programme on HIV/AIDS, Geneva.
131. Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, BassettIV, Morris BL, Freedberg KA, Paltiel AD, et al. 2009. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr 56: 26-35.
132. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, Tanton C, Ross D, Everett D, Clayton T, et al. 2008. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 358: 1560-1571.
133. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, Buwembo D, Ssempijja V, Kiwanuka N, Moulton LH, et al. 2009. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: A randomised controlled trial. Lancet 374: 229-237.
134. Weir SS, Fox LJ, De Moya A, Gomez B, Guerrero G, Hassiq SE. 1998. Measuring condom use among sex workers in the Dominican Republic. Int J STD AIDS223-226.
135. Weiss HA, Quigley MA, Hayes RJ. 2000. Male circumcision and risk of HIV infection in sub-Saharan Africa: A systematic review and meta-analysis. AIDS14: 2361-2370.
136. Weiss HA, Thomas SL, Munabi SK, Hayes RJ. 2006. Male circumcision and risk of syphilis, chancroid, and genital herpes: A systematic review and meta-analysis. Sex Transm Infect 82: 101-109.
137. Weller S, Davis K. 2002. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane DB Syst Rev 1: CD003255.
138. Westercamp N, Bailey RC. 2007. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: A review. AIDS Behav 11: 341-355.
139. WHA 5515. 2002. Small pox eradication-destruction of stocks. Fifty-Fifth World Assembly Agenda item 13, 16; 18 May 2002.
140. WHO. 2009. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: Progress report 2009. Geneva, Switzerland.
141. Wilson D, Halperin D. 2008. "Know your epidemic, know your response": A useful approach, if we get it right. Lancet 372: 423-426.
142. Winkelstein W Jr., Samuel M, Padian NS, Wiley JA, Lang W, Anderson RE, LevyJA. 1987. The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health 77: 685-689.
143. Winkelstein W Jr., Wiley JA, Padian NS, M Samuel M, Shiboski S, Ascher MS, Levy JA, et al. 1988. The San Francisco Men's Health Study: Continued decline in HIV seroconversion rates among homosexual/bisexual men. Am J Public Health 78: 1472-1474.
144. Wolfe D, Carrieri P, Shepard D, Walker D. 2010. Treatment and care for HIV-infected injecting drug users: A review of barriers and ways forward. Lancet 376: 355-366.
145. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C, et al. 2007. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: A randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 196: 1500-1508.